Sponsor hub
NYU Langone Health clinical trial failures
Review 114 stopped clinical trials from NYU Langone Health, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 4 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 55
- OTHER/UNKNOWN
- 55
- EFFICACY/FUTILITY
- 2
- SAFETY
- 2
Notable sponsors
- NYU Langone Health
- 114
Related phases
- Phase II
- 39
- Phase IV
- 29
- Phase I
- 22
- Unknown
- 13
- Phase III
- 7
Crawlable stopped-trial records
Open ExploreShowing up to 100 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Unknown Genitourinary Syndrome of Menopause (GSM) trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
The study was placed on hold by the Sponsor for \~1 year. Given the prolonged hold and absence of participant activity, the study was closed.
Phase I Cardiac Arrest trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Temporary hold.
Phase IV Acute Bronchiolitis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Study design proved infeasible on the general inpatient pediatrics unit at the investigation site due to uncontrolled variables and protocol non-adherence.
Phase II Hepatocellular Carcinoma trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study was terminated early by the drug sponsor due to slow accrual and a change in the company's drug development priorities
Phase II NSCLC Stage IV trial by NYU Langone Health. Stop reason: OPERATIONAL.
Terminated due to insufficient enrollment.
Early Phase I Antibody-mediated Rejection trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study no longer had funding and therefore was closed before enrollment began.
Phase I Endometriosis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study terminated due to challenges reaching the target accrual for participation.
Phase II Femoral Shaft Fracture trial by NYU Langone Health. Stop reason: OPERATIONAL.
Withdrawn due to lack of funding.
Phase IV Crohn Disease trial by NYU Langone Health. Stop reason: OPERATIONAL.
Other effective drugs have been introduced to market since the beginning of the study.
Phase IV Arthrofibrosis of Knee trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Study team unable to identify method for approval of the medication as standard of care and compounded.
Phase IV Opioid Pain Medication trial by NYU Langone Health. Stop reason: OPERATIONAL.
Both lack of enrollment as well as study staff turnover
Phase II ACL - Anterior Cruciate Ligament Rupture trial by NYU Langone Health. Stop reason: OPERATIONAL.
COVID-19, Lack of Funding
Phase II Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Study record has been combined with NCT05815173 (Phase I/II study).
Phase IV Total Shoulder Athroplasty trial by NYU Langone Health. Stop reason: OPERATIONAL.
Enrollment rate was slower than anticipated
Phase IV Arthropathy Shoulder trial by NYU Langone Health. Stop reason: OPERATIONAL.
Enrollment rate was slower than anticipated.
Phase IV Opioid Use Disorder trial by NYU Langone Health. Stop reason: OPERATIONAL.
This study was not initiated due to policy changes in Massachusetts (the proposed study sites).
Phase II Arthritis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Difficulties getting subjects recruited and enrolled.
Phase IV Calcific Tendinitis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Enrollment difficulty.
Phase I Prostate Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
Terminated early due to slow accrual in the context of changing practice patterns.
Phase IV Arthrofibrosis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study was not initiated, no participants enrolled.
Phase IV Anemia trial by NYU Langone Health. Stop reason: OPERATIONAL.
Unable to meet enrollment goals.
Phase II Iron-deficiency trial by NYU Langone Health. Stop reason: OPERATIONAL.
Unable to complete enrollment as planned.
Phase IV Cubital Tunnel Syndrome trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Obsolete study
Phase II Hereditary Angioedema Types I and II trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI indicated departure from institution, inability to complete study.
Phase III Tinnitus trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI departure from the institution.
Phase IV Chronic Kidney Diseases trial by NYU Langone Health. Stop reason: OPERATIONAL.
loss of funding
Phase II COVID-19 trial by NYU Langone Health. Stop reason: OPERATIONAL.
Investigator decision
Phase I Esophageal Squamous Cell Carcinoma trial by NYU Langone Health. Stop reason: OPERATIONAL.
The study was stopped earlier than anticipated due to slow accrual
Early Phase I Premature Birth trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
The study was stopped due to lack of study staff and inability to enroll subjects into the study due to restrictive inclusion criteria.
Phase IV Ankle Fractures trial by NYU Langone Health. Stop reason: OPERATIONAL.
there was no funding to begin the study
Phase IV Herpes Simplex Virus Keratitis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Unable to enroll participants
Unknown Pain, Postoperative trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Did not have the staff to conduct the study
Phase II Multiple System Atrophy trial by NYU Langone Health. Stop reason: EFFICACY/FUTILITY.
Interim analysis showed early evidence of futility of sirolimus. Trial stopped per DSMB recommendation.
Phase II Small Cell Lung Cancer (SCLC) trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
This study was terminated as the standard of care for small cell lung cancer changed in 2018 to include immunotherapy in the front line setting, making this study no longer clinically relevant.
Phase II Pancreatic Cancer trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI departure from institution
Phase IV Blood Loss trial by NYU Langone Health. Stop reason: OPERATIONAL.
Lack of patient enrollment due to only one surgeon that was enrolling.
Unknown Parkinsons Disease trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI departure from institution
Phase IV Post-Traumatic Stress Disorder trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Difficulty enrolling subjects
Early Phase I Spinal Muscular Atrophy trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
no enrolled prospects
Phase II COVID-19 trial by NYU Langone Health. Stop reason: OPERATIONAL.
This study was withdrawn by the institution to minimize risk to patients and staff with regard to COVID-19.
Phase III DeQuervains Tenosynovitis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
due to PI's change to private practice
Phase IV Prader-Willi Syndrome trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI departure from institution
Phase I Relapsed Hodgkin Lymphoma trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Merck's decision for early termination of the data
Phase IV Osteoarthritis trial by NYU Langone Health. Stop reason: OPERATIONAL.
Low recruitment / DSMB approval to halt recruitment
Phase IV Pancreatic Cancer trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Suspended due to Primary Investigator's decision
Phase II Myelofibroses trial by NYU Langone Health. Stop reason: SAFETY.
Safety concerns
Phase I Alzheimer Disease trial by NYU Langone Health. Stop reason: OPERATIONAL.
Insufficient Enrollment
Early Phase I Bell Palsy trial by NYU Langone Health. Stop reason: OPERATIONAL.
lack of enrollment
Phase II Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI left the institution
Phase I Melanoma trial by NYU Langone Health. Stop reason: OPERATIONAL.
recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
Phase I Melanoma trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Per regulatory coordinator, the sponsor is no longer supporting the study.
Unknown Acne trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
no eligible subjects were enrolled
Phase II Hematopoietic Malignancies trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Procedure has become standard of care - protocol is no longer necessary
Phase III Baker's Cyst trial by NYU Langone Health. Stop reason: OPERATIONAL.
Lack of funding
Phase II Multiple Myeloma trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI left institution.
Phase I Trigger Finger trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No patients were enrolled; Senior author (Dr. Melamed) departed institution
Phase II Glioblastoma trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Due to personnel changes / departure of Dr. Chi.
Phase IV Migraine trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Significant changes have been made to the protocol.
Phase IV Asthma trial by NYU Langone Health. Stop reason: OPERATIONAL.
Difficulty recruiting subjects
Phase IV Systemic Lupus Erythematosus (SLE) trial by NYU Langone Health. Stop reason: OPERATIONAL.
closed in agreement of the sponsor and institution due to lack of patient accrual.
Phase II Nausea trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Unable to begin study with drug provider
Phase IV Myocardial Infarction trial by NYU Langone Health. Stop reason: OPERATIONAL.
feasibility
Phase IV Obesity trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
While 33 people signed consent, no one was enrolled in the study, because none of these patients developed shoulder pain in the recovery room.
Phase I Pancreatic Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
termination because of low accrual; four subjects enrolled and four screen failures.
Phase II Behcet Syndrome trial by NYU Langone Health. Stop reason: OPERATIONAL.
low enrollment
Unknown Cerebral Hyponatremia trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Cutaneous T-cell Lymphoma trial by NYU Langone Health. Stop reason: OPERATIONAL.
Low Accrual
Phase II Avascular Necrosis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Post-traumatic Stress Disorder trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.
Phase III Dysphagia After Anterior Cervical Decompression and Fusion of the Spine trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Breast Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI Left Institution prior to reaching accrual goal and analyzing data.
Phase I Relapsed or Refractory Multiple Myeloma trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI left the institution
Phase II Refractory Multiple Myeloma trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI left the institution
Unknown Migraine trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study team missed continuing review and study lapsed with out recruiting any subjects.
Phase III Post Operative Pain trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Study is currently Lapsed
Phase II Metastatic Melanoma trial by NYU Langone Health. Stop reason: OPERATIONAL.
Study terminated because PI left institution. Planned Statistical analysis not available
Phase II Multiple Myeloma trial by NYU Langone Health. Stop reason: OPERATIONAL.
PI left the institution before all data analysis was completed
Phase IV Multiple Sclerosis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
It was decided on 9/21/2016 to terminate this study early because LogPad devices the patients used to record their injection data was flawed
Phase II Gastric Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
Due to slow accrual
Phase I Ductal Carcinoma in Situ trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
PI has passed away. Requested by department to terminate study.
Phase IV Inflammatory Response trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Samples lost during Hurricane Sandy. Study now taking place at other medical centers.
Phase II Glioma trial by NYU Langone Health. Stop reason: SAFETY.
Novartis paused all study start-up activities due to safety evaluation of IDH305 compound.
Phase I Trauma trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Hyponatremia trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Pancreatic Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
Due to slow accrual
Phase II Soft Tissue Sarcomas trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No patient enrolled as new similar study will be in system within 3 months
Phase IV Uterine Atony trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
Submission discarded. Study never enrolled subjects.
Unknown Renal Dialysis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
07/27/2017 Unable to contact research team to confirm reason for withdrawing study.
Phase II Multiple Myeloma trial by NYU Langone Health. Stop reason: OPERATIONAL.
Due to slow accrual
Unknown Spinal Stenosis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Venous Thromboembolism trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II neurofibromatosis1 (NF1) trial by NYU Langone Health. Stop reason: EFFICACY/FUTILITY.
Sorafenib ineffective for tx of recurrent or progressive PLGA
Unknown Sleep Apnea trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Anesthesia trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II HSAN Type IV trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Brain Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
Due to slow accrual
Unknown Spontaneous Bacterial Peritonitis trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Inflammatory Bowel Disease trial by NYU Langone Health. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Ovarian Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
due to administrative issue and financial sponsor decision to suspend ovarian cancer studies
Phase I Prostate Cancer trial by NYU Langone Health. Stop reason: OPERATIONAL.
due to slow accrual